FDA DEVICE FACTS
Sugita AVM Microclips
Mizuho America, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Sugita AVM Microclips have the same Indications for Use as the predicate device. The Sugita AVM Microclips are designed for occlusion of fragile capillary vessels to stop bleeding from arteriovenous malformations and other analogous venous structures. Sugita AVM Microclips are not intended as a replacement for bipolar electrocoagulation of smaller vessels nor do they negate the need for immediate post-operative angiography following arteriovenous malformation surgery. Comparison of Technological Characteristics to the Predicate Device: Both the Sugita AVM Microclips and the predicate device have the same intended use. Both are intended for occlusion of small vessels in Arteriovenous Malformations (AVM’s) and other similar structures. The materials, design, technological characteristics and operating principles of the current device are unchanged from the predicate cleared through K960037. See the table below. Substantial equivalence in materials, technological characteristics, and performance of the Sugita AVM Microclips to the predicate device is outlined in the table below: Product Sugita AVM Microclips Sugita AVM Microclips
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。